FDA Inspection 1143371 — Front Door Pharmacy, LLC dba Pure Pharmacy (Pure Pharmaceuticals)
The FDA completed an inspection of Front Door Pharmacy, LLC dba Pure Pharmacy (Pure Pharmaceuticals) on June 7, 2021 in Houston, TX. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- June 7, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Houston, TX (United States)